METHODS	After randomization , they were assigned to receive cisplatin 75 mg/m2 every 3 weeks associated with cyclophosphamide 750 mg/m2 ( CC group , n = 22 ) or paclitaxel 175 mg/m2 over a 3-hour infusion ( CP group , n = 24 ) .\